COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 1308: Articles 13071-13080  | Next

What has changed in the experiences of people with mental health problems during the COVID-19 pandemic? Findings from follow-up interviews using a coproduced, participatory qualitative approach
Shah, P., Hardy, J., Birken, M., Foye, U., Rowan Olive, R., Nyikavaranda, P., Dare, C., Stefanidou, T., Schlief, M., Pearce, E., Lyons, N., Machin, K., Jeynes, T., Chipp, B., Chhapia, A., Barber, N., Gillard, S., Pitman, A., Simpson, A., Johnson, S., Lloyd-Evans, B.
10.1101/2021.08.12.21261913 — Posted: 2021-08-13
Mental Health Utilization in Children in the time of COVID-19
Coates, L., Marshall, R., Johnson, K., Foster, B. A.
10.1101/2021.08.11.21261712 — Posted: 2021-08-13
Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: A systematic review and meta-analysis
Fujita-Rohwerder, N., Beckmann, L., Zens, Y., Verma, A.
10.1101/2021.08.11.21261830 — Posted: 2021-08-13
Emergence of SARS-CoV-2 variant B.1.575.2 containing the E484K mutation in the spike protein in Pamplona (Spain) May-June 2021
Trobajo-Sanmartin, C., Miqueleiz, A., Portillo, M. E., Fernandez-Huerta, M., Navascues, A., Sola Sara, P., Lopez Moreno, P., R Ordonez, G., Castilla, J., Ezpeleta, C.
10.1101/2021.08.11.21261950 — Posted: 2021-08-13
The fomite contribution to the transmission of COVID-19 in the UK: an evolutionary population estimate
Meiksin, A.
10.1101/2021.08.11.21261903 — Posted: 2021-08-13
Phylogenetic reconciliation reveals extensive ancestral recombination in Sarbecoviruses and the SARS-CoV-2 lineage
Zaman, S., Sledzieski, S., Berger, B., Wu, Y.-C., Bansal, M. S.
10.1101/2021.08.12.456131 — Posted: 2021-08-13
The impact of school closures on adolescent health-related outcomes during the COVID-19 pandemic: A natural experiment in South Korea
Lee, H., Han, B.
10.1101/2021.08.12.21261943 — Posted: 2021-08-12
Hybrid immunity improves B cell frequency, antibody potency and breadth against SARS-CoV-2 and variants of concern
Andreano, E., Paciello, I., Piccini, G., Manganaro, N., Pileri, P., Hyseni, I., Leonardi, M., Pantano, E., Abbiento, V., Benincasa, L., Giglioli, G., De Santi, C., Fabbiani, M., Rancan, I., Tumbarello, M., Montagnani, F., Sala, C., Montomoli, E., Rappuoli, R.
10.1101/2021.08.12.456077 — Posted: 2021-08-12
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
Corbett, K. S., Gagne, M., Wagner, D., O'Connell, S., Narpala, S. R., Flebbe, D. R., Andrew, S. F., Davis, R. L., Flynn, B., Johnston, T. S., Stringham, C., Lai, L., Valentin, D., Van Ry, A., Flinchbaugh, Z., Werner, A. P., Moliva, J. I., Sriparna, M., O'Dell, S., Schmidt, S. D., Tucker, C., Choi, A., Koch, M., Bock, K. W., Minai, M., Nagata, B. M., Alvarado, G. S., Henry, A. R., Laboune, F., Schramm, C. A., Zhang, Y., Wang, L., Choe, M., Boyoglu-Barnum, S., Shi, W., Lamb, E., Nurmukhambetova, S. T., Provost, S. J., Donaldson, M. M., Marquez, J., Todd, J.-P. M., Cook, A., Dodson, A., Pekosz, A., Boritz, E., Ploquin, A., Doria-Rose, N., Pessaint, L., Andersen, H., Foulds, K. E., Misasi, J., Wu, K., Carfi, A., Nason, M. C., Mascola, J. R., Moore, I. N., Edwards, D. K., Lewis, M. G., Suthar, M. S., Roederer, M., McDermott, A., Douek, D. C., Sullivan, N. J., Graham, B. S., Seder, R. A.
10.1101/2021.08.11.456015 — Posted: 2021-08-12
In vitro determination of inhibitory effects by humic substances complexing Zn and Se on SARS-CoV-2 virus replication
Palyi, B., Kis, Z., Hajdrik, P., Kovacs, N. S., Veres, D. S., Szigeti, K., Hegedus, I., Kovacs, T. J., Bergmann, R. K., Mathe, D.
10.1101/2021.08.11.456012 — Posted: 2021-08-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).